NAXE and ovarian carcinoma: In the field of ovarian cancer, modulation of cholesterol homeostasis seems to modulate platinum sensitivity [41], and in 2013, Fang et al. supported that this process may be triggered by the interplay between apolipoprotein A-I (ApoA-I)-binding protein (AIBP) and angiogenesis [42].